SciBase Holding AB (publ) (STO:SCIB)

Market Cap	511.26M +301.9%
Revenue (ttm)	45.88M +41.2%
Net Income	-90.87M
EPS	-18.52
Shares Out	10.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,888
Open	52.00
Previous Close	50.80
Day's Range	48.20 - 52.70
52-Week Range	18.50 - 54.00
Beta	0.03
Analysts	n/a
Price Target	60.00 (0.0%)
Earnings Date	Aug 19, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 49
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SCIB

Financial Performance

In 2025, SciBase Holding AB's revenue was 40.46 million, an increase of 36.21% compared to the previous year's 29.71 million. Losses were -87.06 million, 32.8% more than in 2024.